Skip to content
LUCEM

EMERGING HEALTH INSIGHTS
FOR A BRIGHTER TOMORROW

PEPTIDE LIBRARY / EXPERT CURATOR

Wolverine Blend

Research, perspectives and original sources

The nickname for pairing two injury-recovery peptides, popular enough that nearly 1,000 patients' charts mention one of them, yet the only study to test the pair together, in rats, found no added benefit.

At a Glance
What is it?A marketing nickname, not a scientific or drug name, for using two lab-made peptides together: BPC-157 (modeled on a protein fragment from stomach fluid) and TB-500 (a synthetic fragment of thymosin beta-4, a repair-related protein).12
Why are people interested?Faster healing of tendons, ligaments, muscle and joints, and getting back to training. People use it for chronic back pain, tendinitis and elbow, wrist or shoulder pain.1
How strong is the evidence?Mostly rodent and cell studies. One rat study tested the pair directly and found the combination no better than TB-500 alone.6 Reviewers say no randomized human trials confirm either peptide's benefit for musculoskeletal injury.5
Is it approved?No. Neither is approved as a medicine in the US, Canada or Australia.29 A US advisory committee voted in July 2026 to recommend both for a compounding list, against FDA staff's advice; that vote is advisory only.8

Research Topics & Potential Applications

1
Tendon, Ligament & Muscle RecoveryEvidence: Mostly Animal & Lab Research
2
Joint & Chronic PainEvidence: We Really Don't Know Yet

Perspectives & Practical Context

Tendon, Ligament & Muscle Recovery

This is the core reason people use the stack, and the discussion comes from podcasts, newsletters, forums and clinics.

  • A clinician guide says patients use stacks for chronic back pain, patellar tendinitis and wrist, elbow and shoulder pain, often sourced from influencers, podcasts or Reddit, and some mix stacks at home.1
  • A review of more than 12,000 Reddit posts, as described by a physician, reported user concerns about side effects, purity and long-term safety; the physician calls this low-quality, anecdotal data.3
  • Marketing also promotes muscle growth, which the evidence we reviewed does not address.2

We could not verify any individual forum thread.

Joint & Chronic Pain

Pain is a common reason people give for trying the stack.

  • A clinician guide describes chronic back pain and tendinitis among the reasons patients report.1
  • In an electronic-health-record preprint, pain and gastrointestinal symptoms were the most common recorded reasons for starting BPC-157; response was recorded for only a third of patients and the data were too limited to establish effects.4

Research & Evidence

Tendon, Ligament & Muscle Recovery

What the Research Says

The only direct test of the pair is in rats. In a 2026 study of 32 rats with transected Achilles tendons, TB-500 alone produced a significant strength gain over untreated controls, BPC-157 alone did not differ significantly, and the combination did not outperform either one alone; the authors list small groups, a single 4-week time point and healthy young male rats as limits.6 A 2025 review of the two peptides found regenerative effects for BPC-157 in animal models such as rat Achilles transection, unproven efficacy of TB-500 in sports injuries, and no published human randomized trials confirming either for musculoskeletal injuries.5 A rehabilitation physician writing in The Conversation calls human evidence for BPC-157 "extremely thin" and "close to nonexistent" for common orthopedic injuries, and notes TB-500 is only a fragment of thymosin beta-4, so research on the full protein does not necessarily apply.3

See the ResearchStudies, numbers and limits

What the rat study does and doesn't say

The result is one small, independent, unfunded rat experiment with a single time point. It is not evidence about people, and not proof that combining peptides can't help. It is the only direct combination data we found, and it did not show added benefit.6

Limitations

  • Animal data cannot be assumed to apply to humans.
  • No controlled human data on the pair exist, as far as we found.
  • FDA's own reviewers recommended against adding BPC-157 and TB-500 to the compounding list, citing insufficient safety, effectiveness and characterization data, although an advisory committee voted the other way (see Regulatory).78
Joint & Chronic Pain

What the Research Says

The closest human data is one small BPC-157 study: 16 people with knee pain, relying on self-assessment with no comparison group, so placebo effects or natural recovery can't be ruled out;3 a health-education article adds that its authors were linked to a clinic that sells the injections.2 We found no human study of TB-500 or of the pair for pain.

See the ResearchStudies, numbers and limits

Why records of use aren't evidence of benefit

The preprint counted 1,039 patients whose doctors documented BPC-157 use, with new documented users rising 33-fold between 2020 and 2026. About half also took other drugs such as testosterone or NSAIDs, and there was no placebo or untreated comparison, so benefit can't be separated from natural recovery or other treatments, according to an outside physician quoted in the coverage.4

Limitations

  • The preprint is not peer-reviewed and covers BPC-157 use, not the combination specifically.4
  • Doctors' notes capture only patients who disclose use.4

Other Areas People Talk About

Gut Health

Research: BPC-157 began as a gut-protection peptide; animal studies report stomach and intestinal protection, and its one human colitis trial exists only as a conference abstract that FDA reviewers judged inadequate.7 TB-500 is not part of that evidence.

Real World: Gastrointestinal symptoms appear among reasons patients start BPC-157, per the records preprint.4

Muscle Growth

Research: Muscle growth is part of the stack's marketing.2 We found no study of either peptide, or the pair, for building muscle in healthy people.

Real World: We found no independent reports specific to this use.

Wolverine vs. GLOW vs. KLOW

The Wolverine stack is the two-peptide recovery pairing. GLOW adds GHK-Cu, a skin-focused ingredient, and KLOW adds KPV on top of that.1 All three are nicknames for unstandardized mixtures rather than defined products.

Each ingredient's page on this site covers its own evidence; the blends themselves have none beyond the single rat study of the BPC-157 plus TB-500 pair.

Safety, Side Effects & Concerns

  • What We Know

    • No safety study of the pair exists, as far as we found; long-term human safety is unknown and interactions are poorly understood.2
    • A clinician guide reports adverse events in people using stacks, including injection-site reactions, infections, full-body hives, hormonal disturbances and insulin resistance, without tying them to a specific stack.1
    • FDA's adverse-event system listed 10 reports tied to BPC-157 since 2021, all serious and eight in 2026; FDA notes such reports do not establish cause.4

    What We Don't Know

    • Whether BPC-157 and TB-500 interact when used together is unknown.
    • Whether either affects cancer risk has not been tested; reviewers note a theoretical concern because both involve blood-vessel growth and cell migration, which also appear in tumor biology, and say this does not prove harm.35
    • Safety in pregnancy and with existing conditions is unstudied for the stack.

    Reported / Identified Concerns

    • FDA reviewers found no human data for most routes of BPC-157 and raised characterization and immunogenicity concerns.7
    • In the records preprint, patients most often stopped because their doctors advised it; others cited neuropsychiatric, dermatologic or gastrointestinal side effects.4
    • Products bought online may differ from their labels and may be contaminated, according to a health-education article and Health Canada.29

Is It Approved or Legal?

Is It Approved or Legal?

Status as of October 2026.

The stack itself

Not a recognized product

"Wolverine stack" is a marketing term, not a scientific one.2 We found no regulatory entry for it as a blend; status depends on each ingredient.

United States (FDA)

Under review

Neither peptide is FDA-approved. At the July 2026 advisory committee, FDA's staff recommended against adding BPC-157 and TB-500 to the 503A compounding list, but the committee voted in favor; this is advisory only and FDA had not issued a final decision as of our research.784 We did not confirm how FDA's compounding framework would treat a two-ingredient mixture; each ingredient would presumably need to be eligible on its own.

Canada (Health Canada)

Not authorized

Health Canada's April 9, 2026 advisory lists BPC-157 and TB-500 among unauthorized injectable peptide products, warning they haven't been assessed for safety, effectiveness or quality and may be illegal to sell. The advisory does not name any stack.9

Australia (TGA)

Prescription-only, unapproved

An Australian health-education article states neither peptide is approved by the TGA, that both are Schedule 4 prescription-only medicines, and that possessing them without a valid prescription is illegal. We did not verify this against TGA documents.2

Sport (WADA)

Prohibited

Sources agree both peptides are banned in sport, though they place them in different categories (S0 non-approved substances in one review, TB-500 under S2 peptide hormones in another source).25 Athletes should confirm with their anti-doping organization.

What We Still Don't Know

What We Still Don't Know

Does using BPC-157 and TB-500 together help tendons or muscle in people?

Not established. No controlled human data exist, and the only direct combination data we found, a rat tendon study, showed no added benefit over TB-500 alone.6

Does either peptide work for human injuries on its own?

Not established. Reviewers describe human evidence as thin to nonexistent for musculoskeletal injuries.35

Is the pair safe over time?

Unknown. No safety study exists, and cancer-risk questions are untested.

What will FDA do about compounding BPC-157 and TB-500?

Unknown. The July 2026 votes are advisory, and FDA is not required to follow them.8

Quality Matters Too.

Quality Matters Too.

Most users get these peptides from compounding pharmacies or gray-market vendors, according to the records preprint.4 Vials sold online can vary in concentration, ingredients and contamination.3

Whether the research supports a use, and whether a vial contains what its label says, are two separate questions.

Explore Safety & Quality

Research & References

Original Sources & References

Every claim on this page traces back to these sources. Open the studies and regulatory documents yourself.

HOW WE RATE THE EVIDENCE
  1. MDLinx, Your clinical guide: managing patients using peptide stacks for chronic pain and anti-aging (May 2026; clinician-facing).MDLinx clinical guide
  2. Healthy Male (Australia), What you need to know about the Wolverine stack (health-education article).Healthy Male
  3. McGuire F., Can peptides help with joint pain and muscle recovery? (republished from The Conversation; University of Utah physical medicine and rehabilitation resident).McGuire, The Conversation
  4. CP24, Use of untested wolverine peptide on the rise, study finds (Sept 16, 2026; reports an nference electronic-health-record preprint of 1,039 patients with documented BPC-157 use, not peer-reviewed).CP24 on nference preprint
  5. "The grey zone" of pharmacology: a review of peptide bioregulators for post-sports injury recovery (BPC-157, TB-500). Physical Culture and Sport: Scientific Perspective 4:14-23 (Dec 2025; abstract).Grey-zone review, 2025
  6. Biçer et al. (2026), Effects of BPC-157 and TB-500 on Achilles tendon healing in rats: a histopathological and biomechanical study. Joint Diseases and Related Surgery 37(3):822-837.Biçer 2026 (rats)
  7. U.S. FDA, Briefing document, Pharmacy Compounding Advisory Committee, July 23–24, 2026: BPC-157-related bulk drug substances.FDA briefing, BPC-157
  8. ABC News, FDA advisory committee votes to add popular peptide BPC-157 to drug compounding list (July 23, 2026).ABC News on PCAC vote
  9. Health Canada public advisory (April 9, 2026), think twice before injecting peptides bought online; lists BPC-157 and TB-500.Health Canada advisory

Where to Next?

Where to Next?
Safety & QualityHow to Read a Peptide COAExploreSee All Peptides A–ZLearnHow We Grade the Evidence

Compare the blends

Explore ingredients and evidence gaps across Wolverine, GLOW and KLOW.

READ THE COMPARISON

Four Views, One Clear Calculation

Reconstitution Calculator

01 / VIAL AMOUNT

Peptide Purchased

Wolverine BlendILLUSTRATION10 mg

Use these buttons to select the amount you would like to reference. The image does not verify a product's contents.

02 / LIQUID VOLUME

BAC Water

Volume changes concentration. No diluent or preparation method is selected by this tool.

03 / MASS TO CONVERT

Peptide Dosage

Need Help?

Enter the amount in mg provided by your clinician or reference. The calculation updates automatically as you type.

04 / VOLUME EQUIVALENT

Draw Amount

00.5 mL1 mL← Enter Dosage

Example concentration
Enter an amount to see the full calculation.

Arithmetic only. This tool does not establish product identity, suitability, stability, sterility, preparation instructions, injection technique, dose or frequency.

View Full Peptide Calculator

Blend calculation: amounts refer to the combined mass of all ingredients. The result does not calculate an individual ingredient’s amount or establish the blend ratio.

Find A Peptide Supplier

Peptides of Interest (optional)
Peptides Interested In:

Select all that apply.

By submitting, you agree that LUCEM may contact you about your research supplier enquiry.

Talk to a real person